MedAdvisor Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Rick Ratliff

Algemeen directeur

AU$1.5m

Totale compensatie

Percentage CEO-salaris	46.9%
Dienstverband CEO	2.3yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2.1yrs
Gemiddelde ambtstermijn bestuur	6yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Rick Ratliff's beloning veranderd ten opzichte van MedAdvisor's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2024	AU$2m	AU$723k	AU$792k
Mar 31 2024	n/a	n/a	-AU$4m
Dec 31 2023	n/a	n/a	-AU$9m
Sep 30 2023	n/a	n/a	-AU$10m
Jun 30 2023	AU$2m	AU$678k	-AU$11m

Compensatie versus markt: De totale vergoeding ($USD 995.82K ) Rick } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Australian markt ($USD 295.69K ).

Compensatie versus inkomsten: De vergoeding van Rick is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Rick Ratliff

2.3yrs

Tenure

AU$1,542,426

Compensatie

Mr. Richard Ratliff, also known as Rick, MBA IT, BChE serves as Chief Executive Officer & Managing Director and Director at MedAdvisor Limited since July 15, 2022. He serves as Chief Commercial Officer at...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Richard Ratliff	CEO, MD & Director	2.3yrs	AU$1.54m	geen gegevens
Ancila Desai	CFO & Joint Company Secretary	2.1yrs	AU$837.50k	geen gegevens
Craig Schnuriger	Acting Chief Technology Officer	4.7yrs	geen gegevens	geen gegevens
James Rotsart	Executive VP of US & Client Relations	no data	geen gegevens	geen gegevens
Wayne Marinoff	President of ANZ	1.8yrs	geen gegevens	geen gegevens
Anshu Raghuvanshi	Joint Company Secretary	1.7yrs	geen gegevens	geen gegevens

2.1yrs

Gemiddelde duur

Ervaren management: Het managementteam van MDR wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.1 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Richard Ratliff	CEO, MD & Director	2.3yrs	AU$1.54m	geen gegevens
Linda Jenkinson	Independent Non-Executive Chairman	2.8yrs	AU$531.73k	geen gegevens
Kevin Hutchinson	Independent Non-Executive Director	2yrs	AU$187.69k	0.071% A$ 116.2k
Lucas Merrow	Independent Non-Executive Director	3.3yrs	AU$137.93k	0.17% A$ 277.4k
Sandra Hook	Independent Non-Executive Director	8.8yrs	AU$202.69k	0.056% A$ 91.3k
Arthur Charlaftis	Member of Advisory Board	8.7yrs	geen gegevens	geen gegevens
Jim Xenos	Non-Executive Director	9yrs	AU$88.46k	1.25% A$ 2.0m
Mike Da Gama	Member of Advisory Board	8.7yrs	AU$25.89k	geen gegevens
Philip England	Member of Advisory Board	8.7yrs	geen gegevens	geen gegevens
Catherine Hill	Independent Non-Executive Director	1.5yrs	AU$131.68k	geen gegevens

6.0yrs

Gemiddelde duur

Ervaren bestuur: De raad van bestuur van MDR wordt beschouwd als ervaren (gemiddelde ambtstermijn 6 jaar).

MedAdvisor Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

MedAdvisor Limited Announces the Resignation of Anthony Tassone as Non-Executive Director

MedAdvisor Limited, Annual General Meeting, Nov 14, 2024

MedAdvisor Limited Announces Board Resignations

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

MedAdvisor Limited Announces Board Changes

Recent updates

New minor risk - Share price stability

New minor risk - Market cap size

MedAdvisor Limited Announces the Resignation of Anthony Tassone as Non-Executive Director

MedAdvisor Limited, Annual General Meeting, Nov 14, 2024

Full year 2024 earnings released: EPS: AU$0.001 (vs AU$0.021 loss in FY 2023)

MedAdvisor Limited Announces Board Resignations

Forecast breakeven date pushed back to 2025

Forecast breakeven date moved forward to 2025

New minor risk - Market cap size

Forecast breakeven date pushed back to 2026

New minor risk - Profitability

Now 24% overvalued after recent price rise

New major risk - Share price stability

Non-Executive Director recently bought AU$1.2m worth of stock

MedAdvisor Limited, Annual General Meeting, Nov 28, 2023

Full year 2023 earnings released: AU$0.021 loss per share (vs AU$0.046 loss in FY 2022)

New minor risk - Share price stability

MedAdvisor Limited Announces Board Changes

First half 2023 earnings released: EPS: AU$0.009 (vs AU$0.02 loss in 1H 2022)

MedAdvisor Limited Provides Revenue Guidance for the First Half of the Fiscal Year 2023

MedAdvisor Limited Appoints Kevin Hutchinson as Director

Less than half of directors are independent

MedAdvisor Limited to Report Q1, 2023 Results on Oct 28, 2022

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited, Annual General Meeting, Nov 30, 2022

Full year 2022 earnings released: AU$0.046 loss per share (vs AU$0.044 loss in FY 2021)

MedAdvisor Limited (ASX:MDR) entered a binding agreement to acquire GuildLink Pty Ltd from Guild Group Holdings Limited for AUD 8 million.

MedAdvisor Limited Announces Executive Changes

MedAdvisor Limited Announces Change of Managing Director

No longer forecast to breakeven

Less than half of directors are independent

MedAdvisor Limited Announces Retirement of Robert Read as CEO

MedAdvisor Limited Announces Board Changes

MedAdvisor Limited to Report First Half, 2022 Results on Feb 25, 2022

MedAdvisor Limited Appoints Raeann Grossman to the Board as A Non-Executive Director

Independent Non-Executive Director Peter Bennetto has left the company

Non-Executive Director recently sold AU$2.5m worth of stock

Less than half of directors are independent

Full year 2021 earnings released

Non-Executive Director has left the company

MedAdvisor Limited announced that it has received AUD 5.25 million in funding

First half 2021 earnings released: AU$0.029 loss per share (vs AU$0.024 loss in 1H 2020)

MedAdvisor Limited to Report First Half, 2021 Results on Feb 25, 2021

New 90-day low: AU$0.34

New 90-day low: AU$0.36

Non-Executive Chairman of the Board recently bought AU$70k worth of stock

MedAdvisor Limited Signs an Additional One-Year Deal with A Major Global Pharmaceutical Company

MedAdvisor Limited Extends Health Programs in the US

New 90-day low: AU$0.38

New 90-day low: AU$0.40

MedAdvisor Limited Launches ePrescribing across Australia

New 90-day low - AU$0.44

Full year earnings released

New 90-day low - AU$0.45

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur